BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 16572457)

  • 1. Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes.
    François M; Richette P; Tsagris L; Fitting C; Lemay C; Benallaoua M; Tahiri K; Corvol MT
    Arthritis Rheum; 2006 Apr; 54(4):1233-45. PubMed ID: 16572457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
    Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
    Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
    Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
    Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediation of interleukin-1beta-induced transforming growth factor beta1 expression by activator protein 4 transcription factor in primary cultures of bovine articular chondrocytes: possible cooperation with activator protein 1.
    Andriamanalijaona R; Felisaz N; Kim SJ; King-Jones K; Lehmann M; Pujol JP; Boumediene K
    Arthritis Rheum; 2003 Jun; 48(6):1569-81. PubMed ID: 12794825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta.
    Raymond L; Eck S; Mollmark J; Hays E; Tomek I; Kantor S; Elliott S; Vincenti M
    J Cell Physiol; 2006 Jun; 207(3):683-8. PubMed ID: 16453302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
    Afif H; Benderdour M; Mfuna-Endam L; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
    Arthritis Res Ther; 2007; 9(2):R31. PubMed ID: 17386086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages.
    Souissi IJ; Billiet L; Cuaz-Pérolin C; Slimane MN; Rouis M
    Exp Cell Res; 2008 Nov; 314(18):3405-14. PubMed ID: 18823978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1beta.
    Benderdour M; Tardif G; Pelletier JP; Di Battista JA; Reboul P; Ranger P; Martel-Pelletier J
    J Rheumatol; 2002 Jun; 29(6):1262-72. PubMed ID: 12064845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.
    Maneiro E; López-Armada MJ; Fernández-Sueiro JL; Lema B; Galdo F; Blanco FJ
    J Rheumatol; 2001 Dec; 28(12):2692-9. PubMed ID: 11764219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.
    Andriamanalijaona R; Kypriotou M; Baugé C; Renard E; Legendre F; Raoudi M; Boumediene K; Gatto H; Monginoux P; Pujol JP
    J Rheumatol; 2005 Oct; 32(10):1958-67. PubMed ID: 16206353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
    Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
    Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis.
    Shakibaei M; John T; Schulze-Tanzil G; Lehmann I; Mobasheri A
    Biochem Pharmacol; 2007 May; 73(9):1434-45. PubMed ID: 17291458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene transfer of type 1 interleukin-1 receptor extracellular-domain complementary DNA into rabbit synovial cell line HIG-82 results in cellular blockade of interleukin-1 signal transduction.
    Mehraban F; Kasturi S
    Arthritis Rheum; 1998 Mar; 41(3):515-24. PubMed ID: 9506580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression.
    Carl VS; Gautam JK; Comeau LD; Smith MF
    J Leukoc Biol; 2004 Sep; 76(3):735-42. PubMed ID: 15218058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1beta-mediated effects in rat chondrocytes.
    Gouze JN; Bordji K; Gulberti S; Terlain B; Netter P; Magdalou J; Fournel-Gigleux S; Ouzzine M
    Arthritis Rheum; 2001 Feb; 44(2):351-60. PubMed ID: 11229466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsp90{beta} and p130(cas): novel regulatory factors of MMP-13 expression in human osteoarthritic chondrocytes.
    Fan Z; Tardif G; Hum D; Duval N; Pelletier JP; Martel-Pelletier J
    Ann Rheum Dis; 2009 Jun; 68(6):976-82. PubMed ID: 18593760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/enhancer-binding proteins in hepatocytes.
    Chew CH; Chew GS; Najimudin N; Tengku-Muhammad TS
    Int J Biochem Cell Biol; 2007; 39(10):1975-86. PubMed ID: 17616429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of C-C chemokines and their receptors in osteoarthritis.
    Yuan GH; Masuko-Hongo K; Sakata M; Tsuruha J; Onuma H; Nakamura H; Aoki H; Kato T; Nishioka K
    Arthritis Rheum; 2001 May; 44(5):1056-70. PubMed ID: 11352237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCAAT/enhancer binding protein beta mediates expression of matrix metalloproteinase 13 in human articular chondrocytes in inflammatory arthritis.
    Hayashida M; Okazaki K; Fukushi J; Sakamoto A; Iwamoto Y
    Arthritis Rheum; 2009 Mar; 60(3):708-16. PubMed ID: 19248099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.